Galbraith Kenneth

Director · Officer · ZYME

As of 2026-09-16, Galbraith Kenneth has 17 Form 4 transactions on record across 1 company — 15 in the trailing 12 months.

Everything this person has disclosed to the SEC on Form 4 — across every company they file for — reconstructed from the public record. A filing history, not a tip sheet.

Reconstructed holdings

Direct: $5.8MIndirect: $0$5.8Mas of 2026-09-16
  • Direct $5.8M
  • Indirect $0
ZYMEdirect222,000 sh$5.8M

Reconstructed from this person's own Form 4 filings — the total each filing reported owning afterward, priced at the close on the as-of date shown. A filed position can lag the real one.

Direct and indirect holdings (e.g. through a trust or fund) are tagged separately, as filed.

Trades by company

ZYME · 17 trades
2026-01-12: Sale, 30,424 sh ($690K)2026-01-12: Award / grant, 216,000 sh ($0)2026-01-12: Option exercise, 64,000 sh ($0)2026-01-12: Option exercise, 64,000 sh ($0)2026-01-12: Award / grant, 222,000 sh ($0)2026-01-12: Award / grant, 144,000 sh ($0)2026-01-05: Sale, 31,686 sh ($795K)2026-01-05: Sale, 22,657 sh ($569K)2026-01-05: Option exercise, 47,668 sh ($0)2026-01-05: Option exercise, 66,666 sh ($0)2026-01-05: Option exercise, 66,666 sh ($0)2026-01-05: Option exercise, 47,668 sh ($0)2025-12-22: Sale, 47,528 sh ($1.3M)2025-12-22: Option exercise, 100,000 sh ($0)2025-12-22: Option exercise, 100,000 sh ($0)2025-01-10: Award / grant, 192,000 sh ($0)2025-01-10: Award / grant, 288,000 sh ($0)

Filing ledger

DateCompanyActionShares @ priceValueOwnership ΔOwned afterFiling
2026-01-12ZYMESale30,424 @ $22.67$690K−11.8% of holding226,842Form 4
2026-01-05ZYMESale31,686 @ $25.10$795K−14.1% of holding193,266Form 4
2026-01-05ZYMESale22,657 @ $25.10$569K−12.5% of holding158,286Form 4
2025-12-22ZYMESale47,528 @ $27.02$1.3M−26.3% of holding133,275Form 4
13 award / exercise / gift records — not counted as purchases
DateCompanyActionSharesOwned afterFiling
2026-01-12ZYMEAward / grant216,000216,000Form 4
2026-01-12ZYMEOption exercise64,000128,000Form 4
2026-01-12ZYMEOption exercise64,000257,266Form 4
2026-01-12ZYMEAward / grant222,000222,000Form 4
2026-01-12ZYMEAward / grant144,000144,000Form 4
2026-01-05ZYMEOption exercise47,668180,943Form 4
2026-01-05ZYMEOption exercise66,66666,668Form 4
2026-01-05ZYMEOption exercise66,666224,952Form 4
2026-01-05ZYMEOption exercise47,6680Form 4
2025-12-22ZYMEOption exercise100,000180,803Form 4
2025-12-22ZYMEOption exercise100,0000Form 4
2025-01-10ZYMEAward / grant192,000192,000Form 4
2025-01-10ZYMEAward / grant288,000288,000Form 4

Source: SEC Form 4 filings. Each row links to its original filing.

Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.